IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Nov 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-11-19

Reporting Person: HOUGEN ELIZABETH L (SVP, Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-19	Common Stock	M	4000	$10.82	Acquired	24055	Direct
2019-11-19	Common Stock	S	4000	$58.80	Disposed	20055	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-19	Employee Stock Option (right to buy)	$10.82	M	4000	Disposed	2020-01-01	Common Stock (4000)	Direct

Footnotes

F1: Acquired as a result of exercising a stock option. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/2015.

F2: Represents the date on which the options are fully exercisable pursuant to the vesting schedule of the grant.